Based on the fact that the anti-MS action of FTY720 is catalyzed by SphK2 as mentioned above (Fischer et al., 2011), it is reasonable to suggest that SphK2 has neuroprotective functions in MS and EAE. The gene discussed is SPHK2; the disease is myeloid sarcoma.